Use of traditional medicine in middle-income countries a WHO-SAGE study
It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of T...
Saved in:
Published in | Health policy and planning Vol. 31; no. 8; pp. 984 - 991 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.10.2016
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM use and the characteristics of those who access it, to inform health policy-makers as countries seek to fulfil the WHO TM strategy 2014–23 and harness TM for population health. Prevalence of reported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007–10. TM users were compared with users of modern healthcare in univariate and multivariate analyses. Characteristics examined included age, sex, geography (urban/rural), income quintile, education, self-reported health and presence of specific chronic conditions. This study found TM use was highest in India, 11.7% of people reported that their most frequent source of care during the previous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast <3% reported TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa; and <2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In univariate analyses, poorer, less educated and rural participants were more likely to be TM-users. In the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less prevalent in TM users. In Ghana and India, lower income, depression and hypertension were associated with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unnecessary, and perhaps futile, to seek to employ TM for population health needs when populations are increasingly using modern medicine.
Il est souvent dit dans la littérature scientifique, les rapports officiels et la presse que 80% des populations asiatiques et africaines ont recours à la médecine traditionnelle (MT) pour satisfaire leurs besoins en matière de soins de santé; toutefois, cette donnée statistique n’a été diffusée pour la première fois qu’en 1983. La présente étude vise à mettre à jour les connaissances sur la prévalence du recours à la MT et les caractéristiques de ceux qui y ont accès, afin d’éclairer les décideurs du secteur de la santé puisque les pays cherchent à se conformer à la stratégie 2014-23 de l ’OMS relative à la MT, et à exploiter la MT au profit de la santé des populations. La prévalence du recours déclaré à la MT a été étudiée chez 35 334 participants du programme OMS-SAGE, interrogés entre 2007 et 2010. On a procédé à une comparaison des personnes qui ont recours à la MT avec celles qui utilisent les soins de santé modernes par le biais d’analyses univariées et multivariées. Les caractéristiques étudiées comprenaient l’âge, le sexe, la géographie (urbaine/rurale), le quintile de revenu, l’éducation, l’état de santé déclaré et la présence de maladies chroniques spécifiques. Cette étude a révélé que le recours à la MT était plus courant en Inde: 11,7% des personnes ont déclaré que la MT était leur source de soins la plus courante au cours des 3 années précédentes; 19,0% ont déclaré avoir eu recours à la MT au cours des 12 mois précédents. En revanche en Chine, au Ghana, au Mexique, en Russie et en Afrique du Sud, <3% ont déclaré la MT comme leur source de soins la plus courante; et<2% ont déclaré avoir eu recours à la MT l’année précédente au Ghana, au Mexique, en Russie et en Afrique du Sud. En analyse univariée, les participants les plus pauvres, les moins instruits et ceux vivant dans les zones rurales étaient plus susceptibles de recourir à la MT. Dans l’analyse multivariée du cas de la Chine, la ruralité, le mauvais état de santé déclaré et la présence d’arthrite ont été associés au recours à la MT; alors que les cas diagnostiqués de diabète, d’hypertension et de cataracte étaient moins fréquents chez les usagers de la MT. Au Ghana et en Inde, le faible revenu, la dépression et l’hypertension ont été associés au recours à la MT. En conclusion, le recours à la MT est moins fréquent qu’on ne l’affirme souvent. Il peut s’avérer inutile, et peut-être futile, de chercher à satisfaire les besoins sanitaires de la population par le biais de la MT lorsque ces populations ont de plus en plus recours à la médecine moderne.
Con frecuencia se afirma en la literatura científica, en los informes oficiales y en la prensa que el 80% de la población asiática y africana utiliza la medicina tradicional (MT) para satisfacer sus necesidades de cuidado de la salud; sin embargo, esta estadística se reportó por primera vez en 1983. Este estudio tuvo como objetivo actualizar los conocimientos de la prevalencia del uso de la MT y las características de las personas que acceden a ella, para informar a los formuladores de política de salud a medida que los países buscan cumplir la estrategia de la OMS MT 2014-23 y aprovechar la MT para la salud de la población. La prevalencia del uso informado de la MT se estudió en 35,334 participantes de la OMS-SAGE (Grupo Estratégico Consejero de Expertos), encuestados en 2007-10. Los usuarios de la MT se compararon con los usuarios del cuidado de la salud moderno en los análisis univariantes y multivariantes. Las características examinadas incluyeron edad, sexo, geografía (urbano/rural), quintil de ingreso, educación, percepción de salud y presencia de enfermedades crónicas específicas. Este estudio encontró que el uso de la MT era más alto en la India, el 11.7% de las personas informaron que su fuente más frecuente de cuidado durante los 3 años anteriores fue la MT; el 19.0% reportó el uso de la MT en los 12 meses anteriores. En contraste <3% mencionó la MT como su más frecuente fuente de cuidado en China, Ghana, México, Rusia y Sudáfrica; y <2% reportó el uso de MT en el año anterior en Ghana, México, Rusia y Sudáfrica. En los análisis univariantes, los más pobres, los menos educados y los participantes rurales eran más propensos a ser usuarios de la MT. En el análisis multivariante de China, la ruralidad, los autoinformes de salud pobre y la presencia de la artritis se asociaron con el uso de la MT; mientras que el diagnóstico de diabetes, hipertensión y cataratas eran menos prevalentes en los usuarios de la MT. En Ghana y en la India, los ingresos más bajos, la depresión y la hipertensión fueron asociados con el uso de la MT. En conclusión, el uso de la MT es menos frecuente de lo que comúnmente se reporta. Puede ser innecesario, y hasta inútil, tratar de emplear la MT para las necesidades de salud de la población cuando las poblaciones están utilizando cada vez más la medicina moderna.
科学文献、官方报告和出版物经常提及80%亚洲和非洲人口 使用传统药物满足他们的医疗需求;但是该数据最初于1983 年提出。本文旨在更新传统药物使用普及性的知识以及使用 人群的特性, 从而提醒医疗政策制定者力求实现世界卫生组织 2014-2023传统药物战略和控制传统药物对人口健康的影响。 披露的传统药物使用的普及性来自对2007-2010年35334名世 界卫生组织——全球老龄化和成人健康组织调查参与者的调 查结果。传统药物使用者与现代医疗使用者在单因素和多因 素分析中进行比较。调查的特征包括年龄、性别、地区性 (城市/乡村) 、收入等级、教育水平、自评健康状况、是否 存在特殊慢性疾病。本研究发现传统药物在印度使用率最高, 11.7%的被调查者表明他们在近3年最常用的医疗方式是传统 药物;19.0%的人回答他们在过去12个月使用过传统药物。相 反, 在中国、加纳、墨西哥、俄罗斯和南非, 低于3%的人将传 统药物当作他们最常用的医疗方式;在加纳、墨西哥、俄罗 斯和南非低于2%的人在过去1年使用传统药物。在多变量分 析中, 较贫困、较低教育水平和乡村地区的被调查者更可能使 用传统药物。在中国多变量分析中, 乡村地区、自评健康条件 较差和存在关节炎的被调查者与传统药物使用相关;然而糖 尿病、高血压和白内障患者更不可能成为传统药物使用者。 在加纳和印度, 较低收入人群、抑郁症和高血压患者更可能使 用传统药物。总之, 传统药物使用没有通常报告中描绘的那样 普遍。当人们更多使用现代药物的时候, 或许没有必要为人口 健康寻求如何探索利用传统药物。 |
---|---|
AbstractList | It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM use and the characteristics of those who access it, to inform health policy-makers as countries seek to fulfil the WHO TM strategy 2014–23 and harness TM for population health. Prevalence of reported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007–10. TM users were compared with users of modern healthcare in univariate and multivariate analyses. Characteristics examined included age, sex, geography (urban/rural), income quintile, education, self-reported health and presence of specific chronic conditions. This study found TM use was highest in India, 11.7% of people reported that their most frequent source of care during the previous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast <3% reported TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa; and <2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In univariate analyses, poorer, less educated and rural participants were more likely to be TM-users. In the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less prevalent in TM users. In Ghana and India, lower income, depression and hypertension were associated with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unnecessary, and perhaps futile, to seek to employ TM for population health needs when populations are increasingly using modern medicine. It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM use and the characteristics of those who access it, to inform health policy-makers as countries seek to fulfil the WHO TM strategy 2014-23 and harness TM for population health. Prevalence of reported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007-10. TM users were compared with users of modern healthcare in univariate and multivariate analyses. Characteristics examined included age, sex, geography (urban/rural), income quintile, education, self-reported health and presence of specific chronic conditions. This study found TM use was highest in India, 11.7% of people reported that their most frequent source of care during the previous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast <3% reported TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa; and <2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In univariate analyses, poorer, less educated and rural participants were more likely to be TM-users. In the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less prevalent in TM users. In Ghana and India, lower income, depression and hypertension were associated with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unnecessary, and perhaps futile, to seek to employ TM for population health needs when populations are increasingly using modern medicine.It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM use and the characteristics of those who access it, to inform health policy-makers as countries seek to fulfil the WHO TM strategy 2014-23 and harness TM for population health. Prevalence of reported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007-10. TM users were compared with users of modern healthcare in univariate and multivariate analyses. Characteristics examined included age, sex, geography (urban/rural), income quintile, education, self-reported health and presence of specific chronic conditions. This study found TM use was highest in India, 11.7% of people reported that their most frequent source of care during the previous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast <3% reported TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa; and <2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In univariate analyses, poorer, less educated and rural participants were more likely to be TM-users. In the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less prevalent in TM users. In Ghana and India, lower income, depression and hypertension were associated with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unnecessary, and perhaps futile, to seek to employ TM for population health needs when populations are increasingly using modern medicine. It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to meet their healthcare needs; however, this statistic was first reported in 1983. This study aimed to update knowledge of the prevalence of TM use and the characteristics of those who access it, to inform health policy-makers as countries seek to fulfil the WHO TM strategy 2014–23 and harness TM for population health. Prevalence of reported use of TM was studied in 35 334 participants of the WHO-SAGE, surveyed 2007–10. TM users were compared with users of modern healthcare in univariate and multivariate analyses. Characteristics examined included age, sex, geography (urban/rural), income quintile, education, self-reported health and presence of specific chronic conditions. This study found TM use was highest in India, 11.7% of people reported that their most frequent source of care during the previous 3 years was TM; 19.0% reported TM use in the previous 12 months. In contrast <3% reported TM as their most frequent source of care in China, Ghana, Mexico, Russia and South Africa; and <2% reported using TM in the previous year in Ghana, Mexico, Russia and South Africa. In univariate analyses, poorer, less educated and rural participants were more likely to be TM-users. In the China multivariate analysis, rurality, poor self-reported health and presence of arthritis were associated with TM use; whereas diagnosed diabetes, hypertension and cataracts were less prevalent in TM users. In Ghana and India, lower income, depression and hypertension were associated with TM use. In conclusion, TM use is less frequent than commonly reported. It may be unnecessary, and perhaps futile, to seek to employ TM for population health needs when populations are increasingly using modern medicine. Il est souvent dit dans la littérature scientifique, les rapports officiels et la presse que 80% des populations asiatiques et africaines ont recours à la médecine traditionnelle (MT) pour satisfaire leurs besoins en matière de soins de santé; toutefois, cette donnée statistique n’a été diffusée pour la première fois qu’en 1983. La présente étude vise à mettre à jour les connaissances sur la prévalence du recours à la MT et les caractéristiques de ceux qui y ont accès, afin d’éclairer les décideurs du secteur de la santé puisque les pays cherchent à se conformer à la stratégie 2014-23 de l ’OMS relative à la MT, et à exploiter la MT au profit de la santé des populations. La prévalence du recours déclaré à la MT a été étudiée chez 35 334 participants du programme OMS-SAGE, interrogés entre 2007 et 2010. On a procédé à une comparaison des personnes qui ont recours à la MT avec celles qui utilisent les soins de santé modernes par le biais d’analyses univariées et multivariées. Les caractéristiques étudiées comprenaient l’âge, le sexe, la géographie (urbaine/rurale), le quintile de revenu, l’éducation, l’état de santé déclaré et la présence de maladies chroniques spécifiques. Cette étude a révélé que le recours à la MT était plus courant en Inde: 11,7% des personnes ont déclaré que la MT était leur source de soins la plus courante au cours des 3 années précédentes; 19,0% ont déclaré avoir eu recours à la MT au cours des 12 mois précédents. En revanche en Chine, au Ghana, au Mexique, en Russie et en Afrique du Sud, <3% ont déclaré la MT comme leur source de soins la plus courante; et<2% ont déclaré avoir eu recours à la MT l’année précédente au Ghana, au Mexique, en Russie et en Afrique du Sud. En analyse univariée, les participants les plus pauvres, les moins instruits et ceux vivant dans les zones rurales étaient plus susceptibles de recourir à la MT. Dans l’analyse multivariée du cas de la Chine, la ruralité, le mauvais état de santé déclaré et la présence d’arthrite ont été associés au recours à la MT; alors que les cas diagnostiqués de diabète, d’hypertension et de cataracte étaient moins fréquents chez les usagers de la MT. Au Ghana et en Inde, le faible revenu, la dépression et l’hypertension ont été associés au recours à la MT. En conclusion, le recours à la MT est moins fréquent qu’on ne l’affirme souvent. Il peut s’avérer inutile, et peut-être futile, de chercher à satisfaire les besoins sanitaires de la population par le biais de la MT lorsque ces populations ont de plus en plus recours à la médecine moderne. Con frecuencia se afirma en la literatura científica, en los informes oficiales y en la prensa que el 80% de la población asiática y africana utiliza la medicina tradicional (MT) para satisfacer sus necesidades de cuidado de la salud; sin embargo, esta estadística se reportó por primera vez en 1983. Este estudio tuvo como objetivo actualizar los conocimientos de la prevalencia del uso de la MT y las características de las personas que acceden a ella, para informar a los formuladores de política de salud a medida que los países buscan cumplir la estrategia de la OMS MT 2014-23 y aprovechar la MT para la salud de la población. La prevalencia del uso informado de la MT se estudió en 35,334 participantes de la OMS-SAGE (Grupo Estratégico Consejero de Expertos), encuestados en 2007-10. Los usuarios de la MT se compararon con los usuarios del cuidado de la salud moderno en los análisis univariantes y multivariantes. Las características examinadas incluyeron edad, sexo, geografía (urbano/rural), quintil de ingreso, educación, percepción de salud y presencia de enfermedades crónicas específicas. Este estudio encontró que el uso de la MT era más alto en la India, el 11.7% de las personas informaron que su fuente más frecuente de cuidado durante los 3 años anteriores fue la MT; el 19.0% reportó el uso de la MT en los 12 meses anteriores. En contraste <3% mencionó la MT como su más frecuente fuente de cuidado en China, Ghana, México, Rusia y Sudáfrica; y <2% reportó el uso de MT en el año anterior en Ghana, México, Rusia y Sudáfrica. En los análisis univariantes, los más pobres, los menos educados y los participantes rurales eran más propensos a ser usuarios de la MT. En el análisis multivariante de China, la ruralidad, los autoinformes de salud pobre y la presencia de la artritis se asociaron con el uso de la MT; mientras que el diagnóstico de diabetes, hipertensión y cataratas eran menos prevalentes en los usuarios de la MT. En Ghana y en la India, los ingresos más bajos, la depresión y la hipertensión fueron asociados con el uso de la MT. En conclusión, el uso de la MT es menos frecuente de lo que comúnmente se reporta. Puede ser innecesario, y hasta inútil, tratar de emplear la MT para las necesidades de salud de la población cuando las poblaciones están utilizando cada vez más la medicina moderna. 科学文献、官方报告和出版物经常提及80%亚洲和非洲人口 使用传统药物满足他们的医疗需求;但是该数据最初于1983 年提出。本文旨在更新传统药物使用普及性的知识以及使用 人群的特性, 从而提醒医疗政策制定者力求实现世界卫生组织 2014-2023传统药物战略和控制传统药物对人口健康的影响。 披露的传统药物使用的普及性来自对2007-2010年35334名世 界卫生组织——全球老龄化和成人健康组织调查参与者的调 查结果。传统药物使用者与现代医疗使用者在单因素和多因 素分析中进行比较。调查的特征包括年龄、性别、地区性 (城市/乡村) 、收入等级、教育水平、自评健康状况、是否 存在特殊慢性疾病。本研究发现传统药物在印度使用率最高, 11.7%的被调查者表明他们在近3年最常用的医疗方式是传统 药物;19.0%的人回答他们在过去12个月使用过传统药物。相 反, 在中国、加纳、墨西哥、俄罗斯和南非, 低于3%的人将传 统药物当作他们最常用的医疗方式;在加纳、墨西哥、俄罗 斯和南非低于2%的人在过去1年使用传统药物。在多变量分 析中, 较贫困、较低教育水平和乡村地区的被调查者更可能使 用传统药物。在中国多变量分析中, 乡村地区、自评健康条件 较差和存在关节炎的被调查者与传统药物使用相关;然而糖 尿病、高血压和白内障患者更不可能成为传统药物使用者。 在加纳和印度, 较低收入人群、抑郁症和高血压患者更可能使 用传统药物。总之, 传统药物使用没有通常报告中描绘的那样 普遍。当人们更多使用现代药物的时候, 或许没有必要为人口 健康寻求如何探索利用传统药物。 |
Author | Kandala, Ngianga-Bakwin Oyebode, Oyinlola Lilford, Richard J Chilton, Peter J |
Author_xml | – sequence: 1 givenname: Oyinlola surname: Oyebode fullname: Oyebode, Oyinlola – sequence: 2 givenname: Ngianga-Bakwin surname: Kandala fullname: Kandala, Ngianga-Bakwin – sequence: 3 givenname: Peter J surname: Chilton fullname: Chilton, Peter J – sequence: 4 givenname: Richard J surname: Lilford fullname: Lilford, Richard J |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27033366$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkb1P3TAUxS1EVR7QsWNRpC5dAtcfsZOlUoWgICF1gdlynJvip8R-2Emr9q_HkAeiSKiD5cG_e3zuOftk1wePhHykcEyh4Se3aDZhOLF_fwNjO2RFhYSSMa52yQqYrEsKNeyR_ZTWAFQIUb0ne0wB51zKFZE3CYvQF1M0nZtc8GYoRuycdR4L54vRdd2ApfM2jFjYMPspOkyH5F1vhoQftvcBuTk_uz69KK9-fL88_XZV2gr4VErbQ2-62iICtr2qmQRpWymwga6vatZ0sgfgppGtqFhruEWDorKNwnyAH5Cvi-5mbrMti_l7M-hNdKOJf3QwTv_74t2t_hl-6QooV0plgS9bgRjuZkyTHl2yOAzGY5iTpjWtOWdU8Yx-foWuwxxzIEkzwSlQqR6po5eOnq08RZoBvgA2hpQi9tq6yTxEmw26QVPQD8XppTi9FJenyldTT8Jv8du9wrz5L_ppQddpCvEZFnUFDZXA7wERfbU7 |
CitedBy_id | crossref_primary_10_29392_001c_13653 crossref_primary_10_1016_j_sajb_2024_04_016 crossref_primary_10_1080_17525098_2023_2252913 crossref_primary_10_60084_hjas_v2i2_208 crossref_primary_10_60084_mp_v1i1_24 crossref_primary_10_36106_paripex_2510301 crossref_primary_10_1007_s00508_020_01625_w crossref_primary_10_1186_s12906_023_04229_9 crossref_primary_10_33084_bjop_v5i1_2968 crossref_primary_10_1080_10520295_2022_2147218 crossref_primary_10_1002_pan3_10249 crossref_primary_10_1155_2021_5537597 crossref_primary_10_5897_AJBR2021_1134 crossref_primary_10_3390_ijms19010263 crossref_primary_10_1155_2021_9991146 crossref_primary_10_1155_2023_2848198 crossref_primary_10_3389_fphar_2021_629935 crossref_primary_10_1007_s44338_024_00027_w crossref_primary_10_1002_acr_23742 crossref_primary_10_1186_s12906_023_03889_x crossref_primary_10_1080_14620316_2022_2046508 crossref_primary_10_1007_s10725_022_00818_9 crossref_primary_10_22270_jddt_v14i12_6916 crossref_primary_10_1007_s42250_020_00195_8 crossref_primary_10_4103_jras_jras_166_22 crossref_primary_10_1002_ptr_8084 crossref_primary_10_1007_s13596_021_00607_1 crossref_primary_10_1080_13549839_2020_1802410 crossref_primary_10_1287_isre_2019_0836 crossref_primary_10_51483_AFJPS_3_1_2023_14_30 crossref_primary_10_1111_tmi_13541 crossref_primary_10_51754_cusbed_1003634 crossref_primary_10_1089_omi_2018_0074 crossref_primary_10_3390_pharmaceutics14051072 crossref_primary_10_1016_j_jep_2024_118913 crossref_primary_10_1017_S0266467421000341 crossref_primary_10_1016_j_jksus_2023_102899 crossref_primary_10_1016_j_scitotenv_2021_146431 crossref_primary_10_4103_ijcfm_ijcfm_65_22 crossref_primary_10_1371_journal_pone_0276325 crossref_primary_10_1016_j_phymed_2018_08_013 crossref_primary_10_52711_2231_5713_2024_00035 crossref_primary_10_1186_s12906_024_04368_7 crossref_primary_10_1080_13880209_2021_1967410 crossref_primary_10_3390_jox13010007 crossref_primary_10_1155_2020_1543831 crossref_primary_10_17584_rcch_2023v17i1_15527 crossref_primary_10_25259_IJMS_285_2020 crossref_primary_10_1371_journal_pone_0313064 crossref_primary_10_1155_2020_1263702 crossref_primary_10_2174_1574885518666230719125554 crossref_primary_10_3390_biology9100313 crossref_primary_10_1007_s11904_022_00602_4 crossref_primary_10_3390_ijms24108918 crossref_primary_10_3390_md22070304 crossref_primary_10_1016_j_ijcard_2021_06_027 crossref_primary_10_1186_s12906_022_03692_0 crossref_primary_10_1055_s_0040_1712757 crossref_primary_10_1016_j_sajb_2019_06_035 crossref_primary_10_1002_jdd_13873 crossref_primary_10_1016_j_heliyon_2023_e19370 crossref_primary_10_1016_j_hermed_2018_06_001 crossref_primary_10_3390_plants13030453 crossref_primary_10_1177_09603271221126487 crossref_primary_10_7759_cureus_64074 crossref_primary_10_1016_j_ajp_2021_102975 crossref_primary_10_2174_0113892037307940240606075208 crossref_primary_10_1155_2018_1903629 crossref_primary_10_1590_1678_4685_gmb_2020_0371 crossref_primary_10_1186_s43088_021_00116_9 crossref_primary_10_1016_j_tfp_2023_100462 crossref_primary_10_1016_j_sajb_2024_10_024 crossref_primary_10_1007_s10722_023_01720_7 crossref_primary_10_1016_j_pce_2022_103232 crossref_primary_10_1016_j_bcab_2024_103374 crossref_primary_10_1016_j_puhe_2019_11_017 crossref_primary_10_3390_antibiotics14030293 crossref_primary_10_4103_bjhs_bjhs_52_20 crossref_primary_10_1007_s11756_021_00932_5 crossref_primary_10_1055_a_2044_9129 crossref_primary_10_1016_j_drup_2020_100695 crossref_primary_10_1016_j_sajb_2025_01_027 crossref_primary_10_3390_ijerph14070737 crossref_primary_10_1186_s13020_021_00491_6 crossref_primary_10_1007_s13596_020_00501_2 crossref_primary_10_1186_s12961_024_01166_y crossref_primary_10_1016_j_eujim_2023_102316 crossref_primary_10_1186_s12981_023_00537_9 crossref_primary_10_1016_j_aimed_2020_11_002 crossref_primary_10_3389_fphar_2025_1475297 crossref_primary_10_1007_s00520_024_09017_w crossref_primary_10_4155_fsoa_2017_0124 crossref_primary_10_1136_bmjopen_2021_054142 crossref_primary_10_1177_15404153241291747 crossref_primary_10_3389_fnut_2021_661455 crossref_primary_10_1093_inthealth_ihz077 crossref_primary_10_1016_j_sciaf_2019_e00108 crossref_primary_10_1371_journal_pone_0308879 crossref_primary_10_1007_s11356_020_10018_5 crossref_primary_10_1155_2019_6587150 crossref_primary_10_3390_app12157493 crossref_primary_10_3390_nu16203496 crossref_primary_10_1016_j_jep_2021_114419 crossref_primary_10_1080_00450618_2016_1273387 crossref_primary_10_1136_bmjopen_2019_029958 crossref_primary_10_33084_bjop_v6i3_4239 crossref_primary_10_3390_biochem1030017 crossref_primary_10_1016_j_cegh_2021_100880 crossref_primary_10_1016_j_heliyon_2024_e38885 crossref_primary_10_1007_s00210_023_02496_4 crossref_primary_10_1186_s12906_021_03247_9 crossref_primary_10_1016_j_chnaes_2022_07_011 crossref_primary_10_1007_s12639_023_01572_z crossref_primary_10_1016_j_phymed_2018_06_007 crossref_primary_10_1007_s10389_020_01343_7 crossref_primary_10_1016_j_jep_2021_114550 crossref_primary_10_1039_D3RA06831E crossref_primary_10_1016_j_hermed_2023_100698 crossref_primary_10_1016_j_intimp_2022_109508 crossref_primary_10_1016_j_heliyon_2023_e15938 crossref_primary_10_1016_j_procbio_2024_07_007 crossref_primary_10_51847_LgpNH7eJuy crossref_primary_10_1016_j_jff_2020_104220 crossref_primary_10_1155_2021_3320325 crossref_primary_10_1007_s12115_024_01032_1 crossref_primary_10_1002_cbdv_202201098 crossref_primary_10_1155_2020_6636766 crossref_primary_10_1186_s12889_020_09479_7 crossref_primary_10_1186_s12906_024_04666_0 crossref_primary_10_1155_2022_8397250 crossref_primary_10_1007_s12687_022_00614_y crossref_primary_10_31083_j_fbl2903111 crossref_primary_10_5897_JMPR2021_7203 crossref_primary_10_1515_chem_2022_0176 crossref_primary_10_3390_ijms252312960 crossref_primary_10_1007_s10459_020_09976_9 crossref_primary_10_1016_j_aimed_2019_02_002 crossref_primary_10_3390_geriatrics4030049 crossref_primary_10_3390_life13020411 crossref_primary_10_1155_2020_8516105 crossref_primary_10_1186_s43088_019_0015_y crossref_primary_10_1186_s12906_021_03432_w crossref_primary_10_1111_nmo_14065 crossref_primary_10_3390_app13053266 crossref_primary_10_3389_fpubh_2023_1104510 crossref_primary_10_1007_s43450_022_00263_9 crossref_primary_10_1016_j_heliyon_2020_e04894 crossref_primary_10_4103_ijar_ijar_20_23 crossref_primary_10_1016_j_chnaes_2022_03_002 crossref_primary_10_18865_1669 crossref_primary_10_18311_jnr_2023_32242 crossref_primary_10_1136_bmjgh_2018_000895 crossref_primary_10_1177_10781552211040725 crossref_primary_10_3390_ijerph18168638 crossref_primary_10_1186_s13002_024_00723_7 crossref_primary_10_1080_2314808X_2022_2045455 crossref_primary_10_1016_j_jep_2023_117333 crossref_primary_10_1002_wmh3_501 crossref_primary_10_1016_j_hermed_2022_100548 crossref_primary_10_1080_10253890_2019_1709435 crossref_primary_10_1016_S1470_2045_21_00720_8 crossref_primary_10_3390_ijms24020915 crossref_primary_10_3889_oamjms_2022_8637 crossref_primary_10_1007_s12010_023_04783_5 crossref_primary_10_3390_biomedicines7030063 crossref_primary_10_1155_2022_7621599 crossref_primary_10_3831_KPI_2022_25_3_209 crossref_primary_10_1016_j_heliyon_2022_e10790 crossref_primary_10_12688_aasopenres_12955_1 crossref_primary_10_2196_25703 crossref_primary_10_1055_s_0043_1760832 crossref_primary_10_1186_s13643_023_02398_9 crossref_primary_10_3390_cancers12082064 crossref_primary_10_4103_ijptr_ijptr_16_23 crossref_primary_10_1038_s41598_024_77796_7 crossref_primary_10_5812_jjcdc_96058 crossref_primary_10_1016_j_obmed_2022_100419 crossref_primary_10_14720_abs_67_1_18390 crossref_primary_10_3390_agronomy14061269 crossref_primary_10_1016_j_jksus_2023_103038 crossref_primary_10_1111_maq_12467 crossref_primary_10_1186_s12906_020_03195_w crossref_primary_10_1016_j_yrtph_2022_105188 crossref_primary_10_1016_j_ajp_2020_102284 crossref_primary_10_7759_cureus_28767 crossref_primary_10_4103_jehp_jehp_704_21 crossref_primary_10_1093_trstmh_traa135 crossref_primary_10_1186_s12889_023_15007_0 crossref_primary_10_3390_molecules25173936 crossref_primary_10_1186_s13033_020_00433_z crossref_primary_10_1007_s40203_024_00287_0 crossref_primary_10_1007_s00240_023_01503_w crossref_primary_10_1016_j_rhum_2017_12_009 crossref_primary_10_1080_21642850_2022_2146585 crossref_primary_10_1016_j_compbiolchem_2023_107826 crossref_primary_10_1016_j_phyplu_2023_100508 crossref_primary_10_1007_s13205_021_02745_4 crossref_primary_10_1093_inthealth_ihz063 crossref_primary_10_3390_ph17121600 crossref_primary_10_7759_cureus_62192 crossref_primary_10_1080_17441692_2023_2191687 crossref_primary_10_1186_s12906_023_03972_3 crossref_primary_10_52711_0974_360X_2024_00207 crossref_primary_10_1080_10130950_2019_1707000 crossref_primary_10_18052_www_scipress_com_IJPPE_13_45 crossref_primary_10_1002_14651858_CD013391 |
Cites_doi | 10.1136/bmj.315.7100.115 10.1097/NMD.0b013e3181a61dbc 10.1016/j.healthpol.2010.04.006 10.1093/ije/dys210 10.7314/APJCP.2013.14.6.3593 10.4103/0019-557X.119818 10.1016/S1470-2045(14)70029-4 10.1016/j.socscimed.2012.05.032 10.1016/j.aogh.2014.04.013 10.1016/j.healthpol.2004.05.008 10.2471/BLT.07.042820 10.1057/jphp.2011.26 10.1016/S0140-6736(09)61261-7 10.1136/bmj.f4145 10.1192/bjp.183.4.349 10.1093/heapol/czs010 10.1016/j.jep.2012.07.017 10.3389/fphar.2013.00177 10.1186/s12913-014-0560-y 10.1097/00002030-199702000-00013 10.1186/1472-6882-14-504 10.1186/1746-4269-7-39 |
ContentType | Journal Article |
Copyright | The Author 2016 The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. 2016 The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. |
Copyright_xml | – notice: The Author 2016 – notice: The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. 2016 – notice: The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. |
DBID | TOX AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QJ 7T2 7TQ 8BJ C1K DHY DON FQK JBE K9. 7X8 5PM |
DOI | 10.1093/heapol/czw022 |
DatabaseName | Oxford Journals Open Access (Activated by CARLI) CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Applied Social Sciences Index & Abstracts (ASSIA) Health and Safety Science Abstracts (Full archive) PAIS Index International Bibliography of the Social Sciences (IBSS) Environmental Sciences and Pollution Management PAIS International PAIS International (Ovid) International Bibliography of the Social Sciences International Bibliography of the Social Sciences ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Health & Safety Science Abstracts International Bibliography of the Social Sciences (IBSS) Applied Social Sciences Index and Abstracts (ASSIA) PAIS International Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: TOX name: Oxford Journals Open Access Collection url: https://academic.oup.com/journals/ sourceTypes: Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health Medicine Geography |
EISSN | 1460-2237 |
EndPage | 991 |
ExternalDocumentID | PMC5013777 27033366 10_1093_heapol_czw022 10.1093/heapol/czw022 48509160 |
Genre | Journal Article |
GeographicLocations | Mexico South Africa Ghana China Russia India |
GeographicLocations_xml | – name: South Africa – name: Mexico – name: China – name: Russia – name: Ghana – name: India |
GrantInformation_xml | – fundername: Department of Health grantid: WMCLAHRC-2014-1 |
GroupedDBID | --- -E4 .2P .I3 .ZR 0R~ 18M 1TH 29I 2WC 4.4 482 48X 5GY 5VS 5WA 70D A8Z AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPNW AAPQZ AAPXW AARHZ AAUQX AAVAP AAWTL AAZDW ABBHK ABEJV ABEUO ABGNP ABIVO ABIXL ABKDP ABLJU ABNKS ABPQP ABPTD ABQLI ABWST ABXSQ ABXVV ABYLZ ABZBJ ACGFO ACGFS ACHQT ACPRK ACUFI ACUTJ ACUTO ACVHY ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADMHG ADOCK ADQBN ADRTK ADULT ADVEK ADYVW ADZXQ AEGPL AEJOX AEKSI AEMDU AENEX AENZO AEPUE AETBJ AEUPB AEWNT AFFZL AFIYH AFOFC AFRAH AGINJ AGKEF AGQXC AGQZG AGSYK AHMBA AHXPO AIAGR AIJHB AILCM AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX AMHCJ AMNDL APIBT APWMN AXUDD BAWUL BAYMD BEYMZ BHONS BTRTY BVRKM BWUDY C45 CDBKE CNZYI CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EJD EMOBN F5P F9B FLUFQ FOEOM FOTVD FQBLK FTKQU GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IOX J21 JENOY JKPJF JPL JPM JST JVCUD JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN M-Z MS~ N9A NGC NOMLY NOYVH NPJNY NVLIB O9- OAWHX ODMLO OJQWA OK1 OPAEJ P2P PAFKI PEELM PQQKQ Q1. Q5Y R44 RD5 ROL ROZ RPM RUSNO RW1 RXO SA0 SV3 TJX TMA TOX TR2 W8F WH7 WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 53G AAPGJ AAWDT ABNGD ABQTQ ABSMQ ACFRR ACPQN ACUKT ADMTO ADPDF AEAAH AEHUL AEKPW AFSHK AFYAG AGKRT APJGH AQDSO AQKUS ASPBG ATTQO AVWKF AZFZN BZKNY C1A CAG COF EGZRM EIHJH FEDTE GROUPED_DOAJ HVGLF M49 MBLQV NTWIH NU- O0~ OBFPC O~Y PB- PMFND QBD RIG RNI RZF RZO YHZ ~OX ~OY ~P0 AAYXX AGQPQ AHGBF CITATION PMKZF PVKVW CGR CUY CVF ECM EIF NPM 7QJ 7T2 7TQ 8BJ C1K DHY DON FQK JBE K9. 7X8 5PM |
ID | FETCH-LOGICAL-c503t-6cf0fad8cee0ebf782606cb64e90df5829d6f003a96b452ba3ceae45c97ec9703 |
IEDL.DBID | TOX |
ISSN | 0268-1080 1460-2237 |
IngestDate | Thu Aug 21 18:15:10 EDT 2025 Fri Jul 11 08:19:37 EDT 2025 Mon Jun 30 07:45:57 EDT 2025 Mon Jul 21 05:51:14 EDT 2025 Tue Jul 01 01:15:50 EDT 2025 Thu Apr 24 22:57:05 EDT 2025 Wed Apr 02 07:02:01 EDT 2025 Thu Jun 19 22:29:36 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Medicine traditional health policy World Health Organization developing countries |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. The Author 2016. Published by Oxford University Press in association with The London School of Hygiene and Tropical Medicine. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c503t-6cf0fad8cee0ebf782606cb64e90df5829d6f003a96b452ba3ceae45c97ec9703 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://dx.doi.org/10.1093/heapol/czw022 |
PMID | 27033366 |
PQID | 2431016773 |
PQPubID | 34190 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5013777 proquest_miscellaneous_1818332173 proquest_journals_2431016773 pubmed_primary_27033366 crossref_citationtrail_10_1093_heapol_czw022 crossref_primary_10_1093_heapol_czw022 oup_primary_10_1093_heapol_czw022 jstor_primary_48509160 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-10-01 |
PublicationDateYYYYMMDD | 2016-10-01 |
PublicationDate_xml | – month: 10 year: 2016 text: 2016-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | Health policy and planning |
PublicationTitleAlternate | Health Policy Plan |
PublicationYear | 2016 |
Publisher | Oxford University Press Oxford Publishing Limited (England) |
Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
References | 2016090705530080000_31.8.984.30 2016090705530080000_31.8.984.29 2016090705530080000_31.8.984.28 2016090705530080000_31.8.984.23 2016090705530080000_31.8.984.21 2016090705530080000_31.8.984.20 2016090705530080000_31.8.984.27 2016090705530080000_31.8.984.26 2016090705530080000_31.8.984.25 2016090705530080000_31.8.984.24 2016090705530080000_31.8.984.5 2016090705530080000_31.8.984.4 2016090705530080000_31.8.984.3 2016090705530080000_31.8.984.2 2016090705530080000_31.8.984.9 2016090705530080000_31.8.984.7 2016090705530080000_31.8.984.6 Peltzer (2016090705530080000_31.8.984.22) 2009; 374 Ekor (2016090705530080000_31.8.984.8) 2014; 4 2016090705530080000_31.8.984.19 2016090705530080000_31.8.984.18 2016090705530080000_31.8.984.17 2016090705530080000_31.8.984.12 2016090705530080000_31.8.984.34 2016090705530080000_31.8.984.11 2016090705530080000_31.8.984.33 2016090705530080000_31.8.984.10 2016090705530080000_31.8.984.32 2016090705530080000_31.8.984.31 2016090705530080000_31.8.984.1 Mbatha (2016090705530080000_31.8.984.16) 2012; 102(3 Pt 1) 2016090705530080000_31.8.984.15 2016090705530080000_31.8.984.14 2016090705530080000_31.8.984.13 |
References_xml | – ident: 2016090705530080000_31.8.984.11 doi: 10.1136/bmj.315.7100.115 – ident: 2016090705530080000_31.8.984.26 doi: 10.1097/NMD.0b013e3181a61dbc – volume: 102(3 Pt 1) start-page: 129 year: 2012 ident: 2016090705530080000_31.8.984.16 article-title: Sick certificates issued by South African traditional health practitioners: current legislation, challenges and the way forward publication-title: South African Medical Journal (Suid-Afrikaanse tydskrif vir geneeskunde – ident: 2016090705530080000_31.8.984.5 – ident: 2016090705530080000_31.8.984.31 doi: 10.1016/j.healthpol.2010.04.006 – ident: 2016090705530080000_31.8.984.7 – ident: 2016090705530080000_31.8.984.34 – ident: 2016090705530080000_31.8.984.32 – ident: 2016090705530080000_31.8.984.30 – ident: 2016090705530080000_31.8.984.1 – ident: 2016090705530080000_31.8.984.15 doi: 10.1093/ije/dys210 – ident: 2016090705530080000_31.8.984.18 doi: 10.7314/APJCP.2013.14.6.3593 – ident: 2016090705530080000_31.8.984.10 doi: 10.4103/0019-557X.119818 – ident: 2016090705530080000_31.8.984.9 doi: 10.1016/S1470-2045(14)70029-4 – ident: 2016090705530080000_31.8.984.23 doi: 10.1016/j.socscimed.2012.05.032 – ident: 2016090705530080000_31.8.984.25 doi: 10.1016/j.aogh.2014.04.013 – ident: 2016090705530080000_31.8.984.27 doi: 10.1016/j.healthpol.2004.05.008 – ident: 2016090705530080000_31.8.984.28 doi: 10.2471/BLT.07.042820 – ident: 2016090705530080000_31.8.984.29 – ident: 2016090705530080000_31.8.984.21 doi: 10.1057/jphp.2011.26 – volume: 374 start-page: 956 year: 2009 ident: 2016090705530080000_31.8.984.22 article-title: Traditional health practitioners in South Africa publication-title: The Lancet doi: 10.1016/S0140-6736(09)61261-7 – ident: 2016090705530080000_31.8.984.13 doi: 10.1136/bmj.f4145 – ident: 2016090705530080000_31.8.984.33 – ident: 2016090705530080000_31.8.984.19 – ident: 2016090705530080000_31.8.984.20 doi: 10.1192/bjp.183.4.349 – ident: 2016090705530080000_31.8.984.24 doi: 10.1093/heapol/czs010 – ident: 2016090705530080000_31.8.984.2 – ident: 2016090705530080000_31.8.984.3 doi: 10.1016/j.jep.2012.07.017 – volume: 4 start-page: 177 year: 2014 ident: 2016090705530080000_31.8.984.8 article-title: The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety publication-title: Frontiers in Pharmacology doi: 10.3389/fphar.2013.00177 – ident: 2016090705530080000_31.8.984.12 – ident: 2016090705530080000_31.8.984.4 doi: 10.1186/s12913-014-0560-y – ident: 2016090705530080000_31.8.984.14 doi: 10.1097/00002030-199702000-00013 – ident: 2016090705530080000_31.8.984.17 doi: 10.1186/1472-6882-14-504 – ident: 2016090705530080000_31.8.984.6 doi: 10.1186/1746-4269-7-39 |
SSID | ssj0014445 |
Score | 2.5740275 |
Snippet | It is frequently stated in the scientific literature, official reports and the press that 80% of Asian and African populations use traditional medicine (TM) to... |
SourceID | pubmedcentral proquest pubmed crossref oup jstor |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 984 |
SubjectTerms | Access Adult Aged Arthritis Cataracts Chronic conditions Chronic Disease Chronic illnesses Developing Countries Diabetes Diabetes mellitus Female Geography Health care Health care policy Health education Health needs Health Policy Health services Health Surveys Humans Hypertension Income Low income groups Male Medicine Medicine, Traditional - statistics & numerical data Middle Aged Multivariate analysis Original ORIGINAL ARTICLES Policy making Populations Rural areas Rural Population Rural schools Rurality Socioeconomic Factors Traditional medicine World Health Organization |
Subtitle | a WHO-SAGE study |
Title | Use of traditional medicine in middle-income countries |
URI | https://www.jstor.org/stable/48509160 https://www.ncbi.nlm.nih.gov/pubmed/27033366 https://www.proquest.com/docview/2431016773 https://www.proquest.com/docview/1818332173 https://pubmed.ncbi.nlm.nih.gov/PMC5013777 |
Volume | 31 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NS8MwFA-ykyDit_OLCOLJYmg-mnoTcRRBd3G4W0naBAfaDbsh-Nf7knTFTUUP7SUvaXkvyfvK-wWhs9KlilSqI6Y5vKiWkVZERqXVxBJoKEpXKHz_ILIBuxvyYRPvqH9I4af0Ejalyfjlsvh4B30Dmy0oYAeS_9gftukCxvxtxOBPOKxSSRowzW-9F5RPOH-4VNj2xb5cPib5Re_0NtB6YzDi6yDhTbRiqi20FqJtOBQRbaNsUBs8thgGKEchuofnWXM8qvCrD0NEDonh1WB_P4Rzka-wwk9ZP3JpJeyBZnfQoHf7eJNFzR0JUcEJnUaisMSqUoKuI0Zb0PfgkRRaMJOS0nIZp6WwsHJVKjTjsVa0MMowXqSJgYfQXdSpxpXZR1jF4OpJZjVPDNPCamcaEgfebXlKjeyiiznz8qIBEHf3WLzkIZFN88DrPPC6i85b8klAzviNcNdLoqVi0lkxgnTRKYjmr85Hc8Hlzeqr8xisIldekVAYom2GdeOSIaoy41mdg2UjKQWHDGj2gpzbL8XAF0qF6KJkYQa0BA6Te7GlGj17bG7uIRyTg3_8-iFaBetLhJOBR6gzfZuZY7BwpvrEB51O_Bz_BKZc_Qk |
linkProvider | Oxford University Press |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+traditional+medicine+in+middle-income+countries%3A+a+WHO-SAGE+study&rft.jtitle=Health+policy+and+planning&rft.au=Oyebode%2C+Oyinlola&rft.au=Kandala%2C+Ngianga-Bakwin&rft.au=Chilton%2C+Peter+J&rft.au=Lilford%2C+Richard+J&rft.date=2016-10-01&rft.pub=Oxford+University+Press&rft.issn=0268-1080&rft.eissn=1460-2237&rft.volume=31&rft.issue=8&rft.spage=984&rft.epage=991&rft_id=info:doi/10.1093%2Fheapol%2Fczw022&rft_id=info%3Apmid%2F27033366&rft.externalDocID=PMC5013777 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0268-1080&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0268-1080&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0268-1080&client=summon |